Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With Osteosarcoma
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Cabozantinib
Related studies linked through entity extraction aliases.
caBozantinib in Pre-treated pAtients With Metastatic COlorectal Cancer.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial
- Status
- RECRUITING
- Phase
- PHASE2
Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Cabozantinib In Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Pilot Phase II Study of Maintenance Cabozantinib Plus Pembrolizumab for Patients With Metastatic Squamous Non-Small Cell Lung Cancer (sqNSCLC)
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Cabozantinib for Patients With Recurrent or Progressive Meningioma
- Status
- RECRUITING
- Phase
- PHASE2
Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
- Status
- RECRUITING
- Phase
- PHASE2
Multiparametric Assessment of Bone Response in mCRPC Patients Treated With Cabozantinib
- Status
- COMPLETED
- Phase
- PHASE2
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
- Status
- RECRUITING
- Phase
- PHASE2